SpiroChem was incorporated in 2011 and has now established as the best-in-class chemistry services and solutions provider for the life science industry. We have developed new concepts for acceleration of research programs at the discovery stage, allowing our clients to advance their projects more rapidly and with a higher chance success. We cover the full range of services, from libraries for screening to late-stage lead optimization and route-scouting to allow for production of larger quantities of clinical candidates. Our focus has been on the synthetic chemistry aspects so far, but we are no expanding outside of our area of expertise to explore AI applications (Innosuisse), computational chemistry support and soon screening services. Future growth will be both organic and by acquisition
Spirochem acquires Canadian biotech company (startupticker.ch)
Applications are open for Venture Leaders China Roadshow 2019 (venturelab.swiss)
Spirochem completes fundraise to support accelerated growth (startupticker.ch)
SpiroChem ready for further growth (startupticker.ch)
Production of bicyclo[1.1.1]pentanes on pilot scale starts!
SpiroChem highlighted in Handelszeitung: handelszeitung | Nr. 20 | 19. Mai 2016 | page 15
Technology Transfer to CMO partner for pilot-scale production of bicyclo[1.1.1]pentanes ongoing
Patent filed !!! This will protect SpiroChem's leadership on bicyclo[1.1.1]pentanes, a class of highly valuable and sought-after building blocks for medinical chemistry
Second CTI grant awarded to SpiroChem (415 kCHF) for design of proprietary fragment libraries
Convertible Loan - Funding to accelerate expension secured
SpiroChem selected by Bilan Magazine as one of the TOP “50 Swiss Start-Up's in which to invest”
500kCHF grant received from CTI to develop novel processes and chemistry technology
Hiring of Business Development Manager
Successfull Seed Round Completed
Awarded ETH Spin-off status
VentureKick Phase I
Venture Leaders China Kick-off